Variant CJD infection in the spleen of a neurologically asymptomatic UK adult patient with haemophilia.
about
Multifaceted Role of Sialylation in Prion DiseasesIs solvent/detergent plasma better than standard fresh-frozen plasma? A systematic review and an expert consensus documentGenetics of Prion Disease in CattlePreclinical deposition of pathological prion protein in muscle of experimentally infected primatesRe-assessment of PrP(Sc) distribution in sporadic and variant CJDThe safety of pharmacologic options for the treatment of persons with hemophilia.Preclinical detection of variant CJD and BSE prions in blood.Parvovirus transmission by blood products - a cause for concern?Differential diagnosis of Jakob-Creutzfeldt diseasePrion removal capacity of plasma protein manufacturing processes: a data collection from PPTA member companies.Advanced tests for early and accurate diagnosis of Creutzfeldt-Jakob disease.Biology and genetics of prions causing neurodegenerationDistribution and Quantitative Estimates of Variant Creutzfeldt-Jakob Disease Prions in Tissues of Clinical and Asymptomatic PatientsQuality and Safety in Blood Supply in 2010Postmortem findings in a case of variant Creutzfeldt-Jakob disease treated with intraventricular pentosan polysulfate.Accelerated, spleen-based titration of variant Creutzfeldt-Jakob disease infectivity in transgenic mice expressing human prion protein with sensitivity comparable to that of survival time bioassay.Can mortality data provide reliable indicators for Creutzfeldt-Jakob disease surveillance? A study in France from 2000 to 2008.Is there a risk of prion-like disease transmission by Alzheimer- or Parkinson-associated protein particles?Five questions on prion diseasesTreatment of hemophilia B: focus on recombinant factor IX.First demonstration of transmissible spongiform encephalopathy-associated prion protein (PrPTSE) in extracellular vesicles from plasma of mice infected with mouse-adapted variant Creutzfeldt-Jakob disease by in vitro amplification.Impact of leucocyte depletion and prion reduction filters on TSE blood borne transmission.Principles of treatment and update of recommendations for the management of haemophilia and congenital bleeding disorders in ItalyVariant CJD. 18 years of research and surveillance.Review: contribution of transgenic models to understanding human prion disease.The molecular epidemiology of variant CJD.A standardized comparison of commercially available prion decontamination reagents using the Standard Steel-Binding AssayRed-backed vole brain promotes highly efficient in vitro amplification of abnormal prion protein from macaque and human brains infected with variant Creutzfeldt-Jakob disease agent.Fukuoka-1 strain of transmissible spongiform encephalopathy agent infects murine bone marrow-derived cells with features of mesenchymal stem cells.Candidate cell substrates, vaccine production, and transmissible spongiform encephalopathies.Sensitive and specific detection of sporadic Creutzfeldt-Jakob disease brain prion protein using real-time quaking-induced conversion.The prion protein preference of sporadic Creutzfeldt-Jakob disease subtypes.Preclinical detection of infectivity and disease-specific PrP in blood throughout the incubation period of prion diseasePost-conversion sialylation of prions in lymphoid tissues.Advanced therapies for the treatment of hemophilia: future perspectives.Emerging infectious agents and the nation's blood supply: responding to potential threats in the 21st centuryCharacterization of variant Creutzfeldt-Jakob disease prions in prion protein-humanized mice carrying distinct codon 129 genotypes.Lack of prion infectivity in fixed heart tissue from patients with Creutzfeldt-Jakob disease or amyloid heart disease.Ethics in prion disease.Clinical use of factor VIII and factor IX concentrates
P2860
Q26739884-198AF0AF-2BDC-4912-B3D8-933F2ECD01B5Q26748355-06BEAEE0-82EE-4CB0-8139-E667DC1CFD51Q26783714-0C86F68E-F14E-42E3-A8D0-7FA895D2B4F0Q28476111-DE43FFF5-2E31-4CEE-BBA0-B8FC6F8DA26AQ28534501-E1F37147-533C-4072-829F-D82244DAA5CCQ30249200-83C8A2DD-D2DB-4215-98F5-76A45F199FCCQ30436588-43B96ECA-E1CA-449D-BF8A-CF493CF587A1Q30571511-691C70E3-525B-45B1-8F2A-44E8758EEC1AQ30581034-B9C65FE7-03C2-411E-9E3F-86653E7FC22FQ30582294-5912452D-85E8-409E-9DAA-D660E0F755FAQ31095751-A1C8CD4E-6FCA-41D2-A39C-6C0F303D2F56Q33567229-62D5CA8B-DC0F-41DD-9AA0-7852742CB4B3Q33724583-706073D5-D661-4B9E-AE3C-7142D40ECE6BQ33929726-BAC68DA4-742E-4462-BEED-7C270FB42CF6Q33956775-C7D648A1-71BD-43AB-95C2-E3FB485F75A5Q34057924-8A49F529-402D-40E6-92E7-D69956511666Q34068016-D138DA80-2DB8-48B5-8D4D-A7B48392781EQ34157427-51680B1B-2264-4EA6-9170-B7E5C68ECE3DQ34263032-F5862E4A-0484-408D-89E5-3DA90708DC90Q34329068-9EB7A015-5659-443D-9C36-4BAE39C4E820Q34355775-9D033007-6A93-439D-9148-3DFC25E24B80Q34364427-292EB1B6-6A10-4770-98FD-4219A21ECE18Q34416394-DF9375E8-1C7D-40F8-8F90-B7A6F1EC4DB4Q34453109-BB081F1F-5CC6-4960-8168-09C1AEE5FD3FQ34474868-6C79331C-41A3-48EE-9D99-C33518699B78Q34632274-6058A4E5-DF8B-4C66-B30F-3C55C086B81DQ34840146-711DC198-5E66-43DE-B97B-3779844FF31DQ35036649-A9719F93-80B8-4E72-B0E8-F5DE4EF8E9F6Q35038696-EC02C16B-5AC0-47C9-A3CF-FF4D1E929F7CQ35849097-EF8C3997-D16F-4365-BBB2-D14B784B66E9Q35960528-F895D08E-89A6-453B-B2DF-8E0D9CBA960BQ36332945-97E2761E-CBC3-4E1D-B3D9-D0B5066CE393Q36343836-09195022-A1AA-4901-92F0-488B1BEBC778Q36354943-695F5813-D2EF-4A8C-AFCA-9927F694F050Q36552555-ADB58B10-7DE3-4CDA-A2EB-7B45D4114D16Q36817997-FB83C352-1D56-47DA-B74B-79B12DCD193EQ37048362-62EE50DF-A16F-4FC2-9DC4-AD5B86C5BCA8Q37123552-10D8D6A1-E675-460C-994A-4C9178BA0BD5Q37282279-B8DE90C1-8E7E-4FC4-BAA1-EF63C45EEEA9Q37370356-8DF905DE-4499-446C-BD09-37C60912AFF7
P2860
Variant CJD infection in the spleen of a neurologically asymptomatic UK adult patient with haemophilia.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Variant CJD infection in the s ...... dult patient with haemophilia.
@en
Variant CJD infection in the s ...... dult patient with haemophilia.
@nl
type
label
Variant CJD infection in the s ...... dult patient with haemophilia.
@en
Variant CJD infection in the s ...... dult patient with haemophilia.
@nl
prefLabel
Variant CJD infection in the s ...... dult patient with haemophilia.
@en
Variant CJD infection in the s ...... dult patient with haemophilia.
@nl
P2093
P2860
P1433
P1476
Variant CJD infection in the s ...... dult patient with haemophilia.
@en
P2093
C M Millar
D M Keeling
F G H Hill
H J T Ward
L McCardle
S N Cousens
P2860
P304
P356
10.1111/J.1365-2516.2009.02181.X
P577
2010-01-12T00:00:00Z